Literature DB >> 25550875

Neuroendocrine carcinoma of the larynx with subcutaneous and intramuscular metastases: a case report.

Song Hong1, Lin Li2, Xiwei Liu3, Chongqi Tu3.   

Abstract

Neuroendocrine carcinomas have become increasingly recognized as more reports are emerging to describe these rare tumors. Primary sites include the lung, liver, throat, and other organs. Laryngeal neuroendocrine carcinomas are relatively rare, and the subtypes as well as the prognoses are quite different in most cases. Metastases to the liver, lungs and other parts are common. However, metastases to subcutaneous tissues or muscles have been rarely reported. We report a case of a neuroendocrine carcinoma of the larynx with subcutaneous and muscle metastases.

Entities:  

Keywords:  Laryngeal; metastasis; muscle; neuroendocrine carcinoma; subcutaneous

Mesh:

Year:  2014        PMID: 25550875      PMCID: PMC4270572     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  15 in total

Review 1.  Neuroectodermal neoplasms of the head and neck with emphasis on neuroendocrine carcinomas.

Authors:  Stacey E Mills
Journal:  Mod Pathol       Date:  2002-03       Impact factor: 7.842

2.  Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale.

Authors:  Anna Maria Carlsson
Journal:  Pain       Date:  1983-05       Impact factor: 6.961

Review 3.  Moderately differentiated neuroendocrine carcinoma of the larynx. A clinicopathologic study of 54 cases.

Authors:  B M Wenig; V J Hyams; D K Heffner
Journal:  Cancer       Date:  1988-12-15       Impact factor: 6.860

Review 4.  Cutaneous metastases as an initial manifestation of visceral well-differentiated neuroendocrine tumor: a report of four cases and a review of literature.

Authors:  Jaroslaw Jedrych; Klaus Busam; David S Klimstra; Melissa Pulitzer
Journal:  J Cutan Pathol       Date:  2013-12-03       Impact factor: 1.587

5.  Primary neuroendocrine carcinoma of the liver.

Authors:  Y P Xi; J Y Yu
Journal:  Ultrastruct Pathol       Date:  1986       Impact factor: 1.094

6.  Atypical carcinoid (neuroendocrine carcinoma) of the gingiva: counterpart of a laryngeal tumor.

Authors:  Yoshihiro Abiko; Ikuko Ogawa; Yufo Hattori; Kaoru Kusano; Michiko Nishimura; Tomoyuki Ohuchi; Uichi Abe; Toshiyuki Shibata; Shinji Matsuda; Takashi Takata; Tohru Kaku
Journal:  Pathol Int       Date:  2004-02       Impact factor: 2.534

Review 7.  Small cell neuroendocrine carcinoma of the larynx. A critical review of the literature.

Authors:  D R Gnepp
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  1991       Impact factor: 1.538

Review 8.  Gastric neuroendocrine tumors.

Authors:  Gianfranco Delle Fave; Gabriele Capurso; Bruno Annibale; Francesco Panzuto
Journal:  Neuroendocrinology       Date:  2004       Impact factor: 4.914

Review 9.  Neuroendocrine (Merkel cell) carcinoma of the skin. Its natural history, diagnosis, and treatment.

Authors:  C L Hitchcock; K I Bland; R G Laney; D Franzini; B Harris; E M Copeland
Journal:  Ann Surg       Date:  1988-02       Impact factor: 12.969

10.  A study of moderately differentiated neuroendocrine carcinomas of the larynx and an examination of non-neoplastic larynx tissue for neuroendocrine cells.

Authors:  Jin-Haeng Chung; Seung-Sook Lee; Yoon-Sang Shim; Sang-Yoon Kim; Soon-Yuhl Nam; Dong-Hoon Kim; Kyung-Ja Cho
Journal:  Laryngoscope       Date:  2004-07       Impact factor: 3.325

View more
  2 in total

Review 1.  Should patients with laryngeal small cell neuroendocrine carcinoma receive prophylactic cranial irradiation?

Authors:  Andrés Coca-Pelaz; Kenneth O Devaney; Juan P Rodrigo; Gyorgy B Halmos; Primož Strojan; William M Mendenhall; Avraham Eisbruch; Robert Smee; Kimihide Kusafuka; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-11-03       Impact factor: 2.503

2.  Nomograms Forecasting Long-Term Overall and Cancer Specific Survival of Patients With Head and Neck Neuroendocrine Carcinoma.

Authors:  Ouying Yan; Wenji Xie; Haibo Teng; Shengnan Fu; Yanzhu Chen; Feng Liu
Journal:  Front Oncol       Date:  2021-02-15       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.